PE20121538A1 - THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE - Google Patents

THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE

Info

Publication number
PE20121538A1
PE20121538A1 PE2012000814A PE2012000814A PE20121538A1 PE 20121538 A1 PE20121538 A1 PE 20121538A1 PE 2012000814 A PE2012000814 A PE 2012000814A PE 2012000814 A PE2012000814 A PE 2012000814A PE 20121538 A1 PE20121538 A1 PE 20121538A1
Authority
PE
Peru
Prior art keywords
antihistamine
theobromine
therapeutic combinations
therapeutic
combinations
Prior art date
Application number
PE2012000814A
Other languages
Spanish (es)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of PE20121538A1 publication Critical patent/PE20121538A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE TEOBROMINA Y UNA ANTIHISTAMINA TAL COMO CLORFENIRAMINA, DIFENHIDRAMINA, LORATADINA, DESLORATADINA, ENTRE OTRAS, DONDE DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE LA TOSREFERRING TO A PHARMACEUTICAL COMPOSITION INCLUDING THEOBROMINE AND AN ANTIHISTAMINE SUCH AS CHLORPHENIRAMINE, DIPHENHYDRAMINE, LORATADINE, DESLORATADINE, AMONG OTHERS, WHERE SAID COMPOSITION IS USEFUL IN THE TREATMENT OF COUGH

PE2012000814A 2009-12-14 2010-12-14 THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE PE20121538A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
PE20121538A1 true PE20121538A1 (en) 2012-12-21

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000814A PE20121538A1 (en) 2009-12-14 2010-12-14 THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE

Country Status (17)

Country Link
EP (1) EP2512472A1 (en)
JP (2) JP2013513652A (en)
CN (1) CN102802625A (en)
AU (1) AU2010332495C1 (en)
BR (1) BR112012014159A8 (en)
CA (1) CA2784215A1 (en)
CO (1) CO6541638A2 (en)
GB (1) GB0921803D0 (en)
IL (1) IL220384A0 (en)
MX (1) MX2012006624A (en)
NZ (1) NZ600267A (en)
PE (1) PE20121538A1 (en)
RU (1) RU2012129675A (en)
SG (2) SG10201408374WA (en)
UA (1) UA105827C2 (en)
WO (1) WO2011073647A1 (en)
ZA (1) ZA201204294B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
CN103263533B (en) * 2013-05-31 2014-11-05 杨宏伟 Theobromine composition for treating cough and application and preparation thereof
CN104188998A (en) * 2014-09-18 2014-12-10 中山大学 Naringin and fexofenadine hydrochloride drug composition and preparation thereof
CN104224819B (en) * 2014-09-18 2016-08-17 中山大学 A kind of naringin and levo-cetirizine hydrochloride pharmaceutical composition and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2019634B3 (en) * 1986-04-17 1991-07-01 Alza Corp CHLORPHENIRAMINE THERAPY.
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
JPH10316568A (en) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd Pharmaceutical composition
JP2003012514A (en) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd Medicament composition
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
CA2682730A1 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis

Also Published As

Publication number Publication date
RU2012129675A (en) 2014-01-27
BR112012014159A8 (en) 2017-12-26
AU2010332495A1 (en) 2012-06-21
JP2013513652A (en) 2013-04-22
CN102802625A (en) 2012-11-28
AU2010332495B2 (en) 2015-01-22
AU2010332495C1 (en) 2016-02-11
JP6078605B2 (en) 2017-02-08
CA2784215A1 (en) 2011-06-23
MX2012006624A (en) 2012-10-05
IL220384A0 (en) 2012-08-30
GB0921803D0 (en) 2010-01-27
BR112012014159A2 (en) 2017-08-29
JP2016040280A (en) 2016-03-24
UA105827C2 (en) 2014-06-25
ZA201204294B (en) 2013-02-27
SG10201408374WA (en) 2015-01-29
EP2512472A1 (en) 2012-10-24
WO2011073647A1 (en) 2011-06-23
CO6541638A2 (en) 2012-10-16
SG181603A1 (en) 2012-07-30
NZ600267A (en) 2013-07-26

Similar Documents

Publication Publication Date Title
PE20121538A1 (en) THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE
CR20110609A (en) ANTIMICROBIAL COMPOSITION AND RELATED METHODS OF USE
SV2011004019A (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONS AND ITS USE
BR112013007631A2 (en) implant device, tool and methods related to paranasal sinus treatment
ECSP11011459A (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
AR075442A1 (en) AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
PE20121524A1 (en) COMBINATIONS OF COMPOUNDS INCLUDING INHIBITORS OF HIV INTEGRASE AND OTHER THERAPEUTIC AGENTS
CR20120207A (en) METHODS OF ADMINISTRATION OF A THERAPY WITH PYRFENIDONE
BRPI0822885A2 (en) Oral Care Implement, Method for Administering an Active Agent, and Oral Care Kit
NI200800175A (en) USE OF BENZO-FUSED HETEROCYCLIC SULFAMID DERIVATIVES FOR THE TREATMENT OF SUBSTANCE ABUSE AND ADDICTION.
EA201100358A1 (en) DABIGATRAN FOR INTERTEGUAL SURGICAL CATHETERIZATION OF THE HEART
BR112012015428A2 (en) oral care compositions for use with an oral light device
MX2012007933A (en) Topical transdermal dexmedetomidine compositions and methods of use thereof.
BR112012013487A2 (en) AMANTADINE COMPOSITIONS AND METHODS OF USE
PE20150709A1 (en) BENZAMIDES
CO7131352A2 (en) Topical pharmaceutical compositions
DOP2011000382A (en) HETEROCICLIC SULFONAMIDS, USES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
AR114032A2 (en) 5- (3,4-DICHLORO-PHENYL) -N- (2-HYDROXY-CYCLOHEXYL) -6- (2,2,2-TRIFLUOR-ETOXY) -NICOTINAMIDE AND SALTS THEREOF
AR084652A1 (en) GLYCOLS AS INACTIVATING AGENCIES FOR PATHOGENS
BR112012029946A2 (en) encapsulation of lactose matrix ingredients to form active encapsulates
MY175764A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
PE20140409A1 (en) DERIVATIVES OF 4- (5-CYANO-PIRAZOL-1-IL) -PIPERIDINE AS MODULATORS OF GPR 119
CL2009001841A1 (en) Use of a sustained release composition of 4-aminopyridine to prepare a medicament useful for treating multiple sclerosis in a subject.
UY31000A1 (en) OXOISOXAZOLES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES
PE20121537A1 (en) COMBINATION OF THEOBROMINE WITH A DECONGESTIVE

Legal Events

Date Code Title Description
FC Refusal